Jeffrey A. Bluestone
Affiliations: | University of Chicago, Chicago, IL |
Area:
Cell Biology, Immunology, Molecular BiologyGoogle:
"Jeffrey Bluestone"Children
Sign in to add traineeMaria-Luisa Alegre | grad student | Chicago | |
Ingrid C. Rulifson | grad student | 2000 | Chicago |
Keshava Rajagopal | grad student | 2001 | Chicago |
Cristina Penaranda | grad student | 2005-2010 | UCSF (Microtree) |
Anne I Sperling | post-doc | (Neurotree) | |
Leonardo M.R. Ferreira | post-doc | 2016- | UCSF |
Daniel Bryan Goodman | post-doc | 2017- | UCSF (Chemistry Tree) |
Brian T. Fife | post-doc | 2002-2007 | UCSF (Microtree) |
Todd M. Brusko | post-doc | 2008-2011 | (Epi Tree) |
Gaurav Chopra | post-doc | 2013-2016 | UCSF (Computational Biology Tree) |
Collaborators
Sign in to add collaboratorEugene P Brandon | collaborator | (Neurotree) | |
Yapeng Su | collaborator | (Chemistry Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Lebrec H, Bui J, Clingan JM, et al. (2025) Second generation CD2-targeting LFA-3 fusion protein SBT115301 to restore immune homeostasis in autoimmune disease. Iscience. 28: 112447 |
Stoops J, Morton T, Powell J, et al. (2025) Treg cell therapy manufacturability: current state of the art, challenges and new opportunities. Frontiers in Immunology. 16: 1604483 |
Bluestone JA, Burnett BK, Crute CE, et al. (2025) Regulatory T cell therapies to treat autoimmune diseases and transplant rejection. Nature Immunology. 26: 819-824 |
Muller YD, Ho P, Bluestone JA, et al. (2024) Rebalancing the Immune System to Treat Type 1 Diabetes. Cold Spring Harbor Perspectives in Medicine |
Smith JA, Yuen BTK, Purtha W, et al. (2024) Aire mediates tolerance to insulin through thymic trimming of high-affinity T cell clones. Proceedings of the National Academy of Sciences of the United States of America. 121: e2320268121 |
Ho P, Cahir-McFarland E, Fontenot JD, et al. (2024) Harnessing regulatory T cells to establish immune tolerance. Science Translational Medicine. 16: eadm8859 |
Bluestone JA, McKenzie BS, Beilke J, et al. (2023) Opportunities for Treg cell therapy for the treatment of human disease. Frontiers in Immunology. 14: 1166135 |
Goodman DB, Azimi CS, Kearns K, et al. (2022) Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies. Science Translational Medicine. 14: eabm1463 |
VanDyke D, Iglesias M, Tomala J, et al. (2022) Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection. Cell Reports. 41: 111478 |
Su Y, Yuan D, Chen DG, et al. (2022) Multiple early factors anticipate post-acute COVID-19 sequelae. Cell |